EP3897604A4 - Topical compositions - Google Patents

Topical compositions Download PDF

Info

Publication number
EP3897604A4
EP3897604A4 EP19898484.1A EP19898484A EP3897604A4 EP 3897604 A4 EP3897604 A4 EP 3897604A4 EP 19898484 A EP19898484 A EP 19898484A EP 3897604 A4 EP3897604 A4 EP 3897604A4
Authority
EP
European Patent Office
Prior art keywords
topical compositions
topical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19898484.1A
Other languages
German (de)
French (fr)
Other versions
EP3897604A1 (en
Inventor
Perry Forrester
Joshua Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marlinz Pharma LLC
Original Assignee
Marlinz Pharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/225,980 external-priority patent/US10543276B2/en
Application filed by Marlinz Pharma LLC filed Critical Marlinz Pharma LLC
Publication of EP3897604A1 publication Critical patent/EP3897604A1/en
Publication of EP3897604A4 publication Critical patent/EP3897604A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19898484.1A 2018-12-19 2019-03-20 Topical compositions Pending EP3897604A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/225,980 US10543276B2 (en) 2016-08-08 2018-12-19 Topical compositions
PCT/US2019/023203 WO2020131147A1 (en) 2018-12-19 2019-03-20 Topical compositions

Publications (2)

Publication Number Publication Date
EP3897604A1 EP3897604A1 (en) 2021-10-27
EP3897604A4 true EP3897604A4 (en) 2022-08-17

Family

ID=71102691

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19898484.1A Pending EP3897604A4 (en) 2018-12-19 2019-03-20 Topical compositions

Country Status (9)

Country Link
EP (1) EP3897604A4 (en)
JP (1) JP2022518357A (en)
KR (1) KR20210107043A (en)
AU (1) AU2019405915A1 (en)
CA (1) CA3122016A1 (en)
IL (1) IL284072A (en)
MX (1) MX2021006810A (en)
SG (1) SG11202105755PA (en)
WO (1) WO2020131147A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545429B1 (en) * 2002-07-29 2010-12-29 Acrymed, Inc. Compositions containing citric acid for the treatment of nail fungal infections
US8333981B2 (en) * 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060165747A1 (en) * 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
CA2764236A1 (en) * 2009-08-13 2011-02-17 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail
GB2478159A (en) * 2010-02-26 2011-08-31 Lrc Products Composition for the treatment of fungal nail infection
WO2014140507A1 (en) * 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections
US10251858B1 (en) * 2016-08-08 2019-04-09 Marlinz Pharma, LLC Composition for treating fungal infections in nails

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545429B1 (en) * 2002-07-29 2010-12-29 Acrymed, Inc. Compositions containing citric acid for the treatment of nail fungal infections
US8333981B2 (en) * 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020131147A1 *

Also Published As

Publication number Publication date
JP2022518357A (en) 2022-03-15
CA3122016A1 (en) 2020-06-25
MX2021006810A (en) 2021-07-02
EP3897604A1 (en) 2021-10-27
KR20210107043A (en) 2021-08-31
SG11202105755PA (en) 2021-07-29
AU2019405915A1 (en) 2021-06-24
IL284072A (en) 2021-08-31
WO2020131147A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
EP3890761A4 (en) Novel composition
EP3334403A4 (en) Topical compositions
EP3735225A4 (en) Pain-relieving topical compositions
EP3397239A4 (en) Topical compositions
EP3746043A4 (en) Topical compositions
EP3659581A4 (en) Topical composition
EP3871694A4 (en) Composition
EP3882323A4 (en) Composition
EP3999039A4 (en) Pretomanid compositions
IL280533A (en) Topical composition
EP3981256A4 (en) Composition
EP3954721A4 (en) Composition
EP3941942A4 (en) Composition
AU2019245709B2 (en) Non-aluminium antiperspirant compositions
IL277213A (en) Topical composition
EP3804734A4 (en) Topical composition
EP3897732A4 (en) Cannabinoid-containing composition
EP3808785A4 (en) Composition
EP3769784A4 (en) Inflammation-suppressing composition
EP3563843A4 (en) Topical composition
EP3512498A4 (en) Topical anti-inflammatory compositions
EP3985062A4 (en) Composition
EP3681490A4 (en) Topical compositions
EP3914076A4 (en) Anti-apicomplexan compositions
EP3804720A4 (en) Delamanid-containing composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220718

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/26 20060101ALI20220712BHEP

Ipc: A61K 47/18 20170101ALI20220712BHEP

Ipc: A61K 47/10 20170101ALI20220712BHEP

Ipc: A61K 31/454 20060101ALI20220712BHEP

Ipc: A61K 31/4174 20060101ALI20220712BHEP

Ipc: A61K 31/137 20060101ALI20220712BHEP

Ipc: A61K 9/06 20060101ALI20220712BHEP

Ipc: A61P 31/10 20060101ALI20220712BHEP

Ipc: A61K 47/14 20170101ALI20220712BHEP

Ipc: A61K 47/12 20060101ALI20220712BHEP

Ipc: A61K 31/34 20060101ALI20220712BHEP

Ipc: A61K 31/325 20060101ALI20220712BHEP

Ipc: A61K 31/201 20060101ALI20220712BHEP

Ipc: A61K 31/17 20060101AFI20220712BHEP